Storm Floriane is causing significant disruptions, problems, and damages across Denmark, with the worst impacts felt in Jutland. According to TV2 Weather, the strongest winds are hitting Thorsminde, ...

Much of the recent debate on closing Europe’s innovation gap with the US and China has centred on top-down policy initiatives ...

Novo Nordisk (0QIU – Research Report) received a Hold rating and a DKK600.00 price target from Bernstein analyst Florent Cespedes today. The ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Kwame Raoul’s office sent cease and desist letters to five unnamed medical spas in the Chicago area that were allegedly ...

The Series A funding round was led by New Enterprise Associates (NEA) with participation from new investors, including Eli ...

Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates worldwide. Explore more here.

Financing to support the development of Orbis' pipeline of next-generation macrocycles, nCycles, with an initial focus on valida ...

Novo Holdings today announced its participation in a ?90 million Series A financing for Orbis Medicines. The round was led by New Enterprise Associates (NEA), with participation from new investors ...

Orbis emerged from stealth in February 2024 with $28.1 million in seed funding. The Danish biotech, which aims to flip ...

J.P. Morgan analyst Richard Vosser maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of ...